Navigation Links
Cephalon's 2007 Results Exceed Full Year Sales and Earnings Guidance
Date:2/12/2008

s a component of research and

development or selling, general and administrative, as appropriate.

CEPHALON, INC. AND SUBSIDIARIES

Reconciliation of GAAP Net Income (Loss) to Adjusted Net Income

(Unaudited)

Three Months Ended

December 31,

2007 2006

GAAP NET INCOME (LOSS) $44,182 $(4,909)

Cost of sales adjustments 26,306 (1) 20,958 (1)

Research and development adjustments 2,000 (2) 35,500 (2) (7)

Selling, general and administrative

adjustments 11,191 (3) - (7)

Acquired in-process research and

development - 5,000 (5)

Debt exchange expense - 48,122 (6)

Income taxes (18,149)(4) (30,831)(4) (7)

21,348 78,749

ADJUSTED NET INCOME $65,530 $73,840

BASIC ADJUSTED INCOME PER COMMON SHARE $0.98 $1.20

DILUTED ADJUSTED INCOME PER COMMON

SHARE $0.83 $1.00

WEIGHTED AVERAGE NUMBER OF COMMON

SHARES OUTSTANDING 67,187 61,783

WEIGHTED AVERAGE NUMBER OF COMMON

SHARES OUTSTANDING-ASSUMING DILUTION 78,734 73,633 Notes to Reconciliation of GAAP Net Income (Loss) to Adjusted Net Income

(1) To exclude the on-going amortization of acquired intangible assets.

(2) To exclude charges related to payments for several research and

development collaborations.

(3) To exclude charges related to certain employee
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. CNS Response Announces Fiscal Third Quarter 2007 Results
5. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Martek to Announce Third Quarter 2007 Results on September 5, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... , Aug. 22, 2014 Research and ... "Global and China Gel Permeation Chromatography (GPC) Industry Report ... The Global and China Gel Permeation Chromatography (GPC) Industry ... current state of the global gel permeation chromatography industry ... report provides a basic overview of the industry including ...
(Date:8/22/2014)... 22, 2014 “Our nation's healthcare ... a national disgrace. Furthermore, every governmental and professional ... current, deplorable state of unorganized dysfunction shares in ... to merely serve as a device to use ... colossal failure(s) that have accumulated through the years ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 ... Fertilizer Industry” is a professional and in-depth ... The report provides basic Seaweed Fertilizer information, ... industry chain structure as well as industry ... analysis, including domestic market as well as ...
(Date:8/21/2014)... 21, 2014  Decision Resources Group finds that ... and Mexico currently ... newly approved agents, the anticipated label extension of ... launch of emerging biologics will substantially increase the ... emerging IL-5 inhibitors will introduce a new dynamic to ...
Breaking Biology Technology:Global and China Gel Permeation Chromatography (GPC) Industry Report 2014 25 Great Mistakes in Healthcare and How to Fix Them by Dr. Ira Williams 2Internationals Seaweed Fertilizer Industry 2014 Development Trend Analysis in New Research Study at DeepResearchReports.com 2Internationals Seaweed Fertilizer Industry 2014 Development Trend Analysis in New Research Study at DeepResearchReports.com 3Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 2Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 3
... Event to focus on nanomedical applications in diagnostics, imaging, and ... ... The Nano-Network, Cleveland Clinic,Lerner Research Institute, and Case Western Reserve ... to,explore the use of nanoparticles for diagnostics, imaging and therapeutics,to improve ...
... Calif., July 8 Arete Therapeutics Inc., a,privately-held ... today announced the appointment of,James Sabry, M.D., Ph.D., ... been a strategic advisor and member of the ... Dinesh Patel in the position of,president and chief ...
... ANN ARBOR, Mich., July 8 NanoBio(R) Corp., ... to prevent and treat infectious diseases, today announced ... board of directors., Dr. Dubin currently serves ... a leading healthcare and biotechnology investment banking firm., ...
Cached Biology Technology:NanoMedicine Summit Returns to Cleveland, September 25-26 2NanoMedicine Summit Returns to Cleveland, September 25-26 3NanoMedicine Summit Returns to Cleveland, September 25-26 4Arete Therapeutics Names James Sabry, M.D., Ph.D., President and Chief Executive Officer 2Daniel B. Dubin, M.D., Joins NanoBio Corp.'s Board of Directors 2
(Date:8/21/2014)... they are the ultimate source of all organic matter ... on algae, too, to suck up climate-warming carbon dioxide ... of the ocean. Now, by using a combination of ... that viruses infecting those algae are driving the life-and-death ... stays essentially the same, and this has important implications ...
(Date:8/21/2014)... researchers from Beth Israel Deaconess Medical Center (BIDMC ) ... Most Influential Scientific Minds 2014," a comprehensive list ... web resource for science metrics and research performance analysis. ... most influential "are performing and publishing work that their ... science," according to a Thomson Reuters statement. Researchers were ...
(Date:8/21/2014)... 18-22, 2014 , WHERE: , San Diego ... CA 92101 , WHAT: , Invited and ... latest research in human genetics. Examples of sessions ... on rare genetic variants in health and disease, ... sun sensitivity (Saturday, Oct. 18, 5:30-7:30 pm) , ...
Breaking Biology News(10 mins):Viruses take down massive algal blooms, with big implications for climate 2BIDMC researchers named among 'the most influential scientific minds' 2BIDMC researchers named among 'the most influential scientific minds' 3American Society of Human Genetics 2014 Annual Meeting 2
... mothers are at risk for iron deficiency, which could ... be presented Saturday, April 30, at the Pediatric Academic ... adults, obesity-related inflammation hinders the transport of iron through ... When a woman is pregnant, iron is transferred through ...
... Federal Court of Appeals has overturned an August 2010 ban ... way for broader exploration of how stem cells function and ... of currently incurable diseases. The ruling has been welcomed ... in 2009, and by the nation,s top researchers in the ...
... New Rochelle, NY, April 29, 2011Videoscopy, a ... monthly publication, Journal of Laparoendoscopic & ... by Mary Ann Liebert, Inc., publishers ( ... fully peer-reviewed surgical and microinvasive demonstrations of ...
Cached Biology News:US Appeals Court opens federal funding for stem cell research 2Groundbreaking minimally invasive surgical videojournal launched by Mary Ann Liebert Inc. 2
Ready-to-use solution....
Applications: ISH...
TRIzol Reagents are ready-to-use monophasic solutions of phenol and guanidine isothiocyanate suitable for isolating total RNA DNA and proteins (16)....
Anti-ZFP-38/RU49 Family: Zinc Finger Peptide Sequence: SVKVEDKDFPSTCSKK...
Biology Products: